Adline Chem Lab quarterly results and financials

Adline Chem Lab (BSE 524604)₹15.790.00%(12 Oct 2026 close)Pharmaceuticals

Key facts

In the Mar 2026 quarter (standalone), Adline Chem Lab reported sales of ₹0 Cr and net profit of −₹0.10 Cr, down 145.5% year on year. For the year to Mar 2026, sales were ₹0 Cr and net profit −₹0.29 Cr.

Sales (Mar 2026): ₹0 Cr
Net profit (Mar 2026): −₹0.10 Cr
Sales (FY Mar 2026): ₹0 Cr
Net profit (FY Mar 2026): −₹0.29 Cr
EPS (Mar 2026): ₹−0.14
Borrowings (Mar 2026): ₹1.80 Cr

Company filings, standalone accounts; latest reported quarter Mar 2026

Adline Chem Lab quarterly results

₹ crore unless stated; each column is a quarter.

Adline Chem Lab Quarterly results
	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Expenses	0.07	0.02	0.00	0.06	0.09	0.06	0.09	0.05	0.02	0.04	0.02	0.07
Operating Profit	−0.09	−0.04	0.00	−0.08	−0.11	−0.08	−0.11	−0.07	−0.04	−0.06	−0.04	−0.09
Other Income	0.00	0.00	0.00	0.02	0.00	0.00	0.00	0.24	0.00	0.00	0.00	0.00
Interest	0.00	0.04	0.04	0.00	0.04	0.04	0.04	0.04	0.04	0.04	0.05	0.05
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	−0.09	−0.07	−0.04	−0.05	−0.14	−0.11	−0.14	0.17	−0.07	−0.09	−0.08	−0.12
Tax %	0.0%	−16.6%	−33.3%	0.0%	−7.7%	−10.0%	−7.6%	−31.2%	−16.7%	−12.5%	−14.3%	−9.1%
Net Profit	−0.09	−0.06	−0.03	−0.05	−0.14	−0.10	−0.13	0.22	−0.06	−0.08	−0.07	−0.10
EPS (Rs)	−0.13	−0.08	−0.02	−0.06	−0.21	−0.14	−0.20	0.35	−0.08	−0.11	−0.09	−0.14

Adline Chem Lab profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Adline Chem Lab Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	16.97	17.21	8.12	5.60	6.60	6.34	0.75	0.00	0.00	0.00	0.00	0.00
Expenses	16.45	15.92	7.21	4.99	9.88	6.54	1.03	0.79	0.17	0.29	0.14	0.15
Operating Profit	0.45	1.22	0.88	0.59	−3.33	−0.24	−0.31	−0.81	−0.19	−0.31	−0.16	−0.23
OPM %	2.6%	7.1%	10.7%	10.4%	−50.4%	−3.6%	−40.6%	—	—	—	—	—
Other Income	0.09	0.07	0.20	0.24	0.25	0.00	1.32	−3.34	0.00	0.24	0.00	0.00
Interest	0.45	0.33	0.35	0.08	0.03	0.04	0.02	0.00	0.13	0.17	0.19	0.18
Depreciation	0.10	0.97	0.74	0.74	0.43	1.03	0.36	0.10	0.00	0.00	0.00	0.00
Profit before tax	0.02	0.02	0.02	0.04	−3.51	−1.29	0.68	−4.25	−0.31	−0.22	−0.33	−0.36
Tax %	100.0%	0.0%	100.0%	0.0%	7.5%	0.0%	−7.4%	0.0%	−10.0%	−33.3%	−12.5%	—
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.99	−3.99	0.00	0.00	0.00	—
Net Profit	0.02	0.02	0.00	0.04	−3.77	−1.29	0.73	−4.24	−0.28	−0.14	−0.29	−0.31
EPS (Rs)	0.01	0.01	0.00	0.04	−6.42	−2.18	1.22	−7.22	−0.45	−0.21	−0.47	−0.42
Dividend payout %	0.0%	0.0%	—	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Adline Chem Lab balance sheet

₹ crore, at each year end.

Adline Chem Lab Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	5.85	5.84	5.84	5.84	5.84	5.85	5.85	5.85	5.85	5.85	5.85	5.85
Reserves	1.22	1.22	1.20	1.19	1.19	−2.64	−3.92	−3.20	−7.42	−7.22	−7.34	−7.62
Borrowings	9.25	8.99	9.93	11.31	5.34	2.85	2.49	1.31	1.33	1.36	1.49	1.80
Other Liabilities	2.33	2.35	3.99	5.04	9.49	1.52	1.21	0.92	0.32	0.07	0.09	0.05
Total Liabilities	18.65	18.40	20.96	23.38	21.86	7.58	5.63	4.88	0.08	0.06	0.09	0.08
Fixed Assets	10.07	10.25	12.66	12.43	11.97	4.77	3.63	4.42	0.00	0.00	0.00	0.00
CWIP	0.19	0.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	8.39	7.96	8.30	10.95	9.89	2.81	2.00	0.46	0.08	0.06	0.09	0.08
Inventories	2.37	1.66	1.95	2.30	3.25	1.10	0.40	0.27	0.00	0.00	0.00	0.00
Trade receivables	2.42	2.49	2.64	2.27	2.07	1.42	1.57	0.06	0.00	0.00	0.00	0.00
Cash & equivalents	0.38	0.23	0.14	1.69	0.18	0.06	−0.17	0.06	0.07	0.05	0.07	0.08
Total Assets	18.65	18.40	20.96	23.38	21.86	7.58	5.63	4.88	0.08	0.06	0.09	0.08

Adline Chem Lab cash flow

₹ crore, for each year.

Adline Chem Lab Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	0.40	0.84	2.47	0.90	−0.96	−11.35	−0.30	0.22	0.02	−0.18	−0.24	−0.17
Cash from investing activity	−2.45	−0.22	−3.19	−0.38	−0.29	11.27	0.13	0.00	0.00	0.00	0.00	0.00
Cash from financing activity	2.17	−0.77	0.62	1.03	−0.28	−0.01	−0.02	0.00	0.00	0.14	0.24	0.15
Net cash flow	0.11	−0.14	−0.08	1.55	−1.50	−0.11	−0.20	0.19	0.00	−0.01	0.01	0.00
Capex	2.44	0.40	3.18	0.52	0.28	0.08	0.00	0.00	0.00	0.00	0.00	0.00
Free cash flow	−2.05	0.61	−0.74	0.35	−1.22	−0.09	−0.16	0.20	0.00	−0.18	−0.24	−0.17
CFO / OP %	41.1%	189.1%	203.1%	102.1%	−163.9%	342.1%	126.1%	−69.9%	−1.0%	94.1%	110.1%	107.1%

Adline Chem Lab ratios

Working-capital days and returns, by year.

Adline Chem Lab Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2026
Debtor days	59	55	57	104	137	80	92	36	—
Inventory days	77	45	55	180	832	81	46	197	—
Days payable	42	40	48	62	436	41	28	341	—
Cash conversion cycle	93	60	64	222	533	120	110	−109	—
Working capital days	25	−6	−30	−140	−318	−72	−67	−765	—
ROCE %	3.4%	2.8%	2.0%	2.0%	0.6%	−40.4%	−23.9%	−11.0%	−933.4%

Adline Chem Lab: frequently asked questions

What are the latest quarterly results of Adline Chem Lab?

For the Mar 2026 quarter, Adline Chem Lab reported sales of ₹0 Cr and net profit of −₹0.10 Cr, down 145.5% year on year.

What is the annual revenue of Adline Chem Lab?

Adline Chem Lab's sales for the year to Mar 2026 were ₹0 Cr; over the last twelve months they were ₹0 Cr.

What is the net profit of Adline Chem Lab?

Net profit for the year to Mar 2026 was −₹0.29 Cr, and −₹0.31 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−0.42.

How much debt does Adline Chem Lab have?

Adline Chem Lab reported borrowings of ₹1.80 Cr at Mar 2026, against cash and equivalents of ₹0.08 Cr.

What is the free cash flow of Adline Chem Lab?

Cash from operations was −₹0.17 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹0.17 Cr.

Loading…